First Trust Nasdaq Lux Digital Health Solutions ETF (EKG)
Holdings of the Fund as of 6/5/2026

Total Number of Holdings (excluding cash): 38

Security Name Identifier CUSIP Classification Shares / Quantity Market Value Weighting Descending sort
IQVIA Holdings Inc. IQV 46266C105 Health Care Providers 1,205 $221,057.25 8.51%
DexCom, Inc. DXCM 252131107 Medical Equipment and Services 2,934 $213,771.24 8.23%
Veeva Systems Inc. (Class A) VEEV 922475108 Health Care Providers 1,183 $204,197.63 7.86%
Intuitive Surgical, Inc. ISRG 46120E602 Medical Equipment and Services 428 $180,641.68 6.96%
ResMed Inc. RMD 761152107 Medical Equipment and Services 841 $164,869.64 6.35%
Guardant Health, Inc. GH 40131M109 Pharmaceuticals and Biotechnology 1,147 $144,074.67 5.55%
Illumina, Inc. ILMN 452327109 Pharmaceuticals and Biotechnology 801 $130,018.32 5.01%
Natera, Inc. NTRA 632307104 Medical Equipment and Services 518 $111,530.58 4.29%
Oscar Health, Inc. (Class A) OSCR 687793109 Life Insurance 4,071 $99,780.21 3.84%
Align Technology, Inc. ALGN 016255101 Medical Equipment and Services 567 $95,108.58 3.66%
Globus Medical, Inc. (Class A) GMED 379577208 Medical Equipment and Services 1,128 $90,240.00 3.47%
Tempus AI, Inc. (Class A) TEM 88023B103 Pharmaceuticals and Biotechnology 1,799 $83,527.57 3.22%
QIAGEN N.V. QGEN N72482156 Medical Equipment and Services 2,163 $79,338.84 3.05%
Hims & Hers Health, Inc. HIMS 433000106 Health Care Providers 2,626 $68,774.94 2.65%
Insulet Corporation PODD 45784P101 Medical Equipment and Services 437 $66,957.14 2.58%
iRhythm Holdings, Inc. IRTC 450056106 Medical Equipment and Services 444 $47,998.63 1.85%
Veracyte, Inc. VCYT 92337F107 Pharmaceuticals and Biotechnology 865 $42,151.45 1.62%
10X Genomics, Inc. (Class A) TXG 88025U109 Pharmaceuticals and Biotechnology 1,323 $41,065.92 1.58%
Doximity, Inc. (Class A) DOCS 26622P107 Health Care Providers 1,935 $39,841.65 1.53%
Adaptive Biotechnologies Corporation ADPT 00650F109 Pharmaceuticals and Biotechnology 2,336 $39,478.40 1.52%
Twist Bioscience Corporation TWST 90184D100 Pharmaceuticals and Biotechnology 569 $39,386.18 1.52%
Establishment Labs Holdings Inc. ESTA G31249108 Medical Equipment and Services 473 $35,148.63 1.35%
Heartflow, Inc. HTFL 42238D107 Pharmaceuticals and Biotechnology 1,235 $34,703.50 1.34%
Privia Health Group, Inc. PRVA 74276R102 Health Care Providers 1,501 $32,466.63 1.25%
Hinge Health, Inc. (Class A) HNGE 433313103 Health Care Providers 498 $31,682.76 1.22%
Waystar Holding Corp. WAY 946784105 Health Care Providers 1,506 $30,120.00 1.16%
Caris Life Sciences, Inc. CAI 142152107 Pharmaceuticals and Biotechnology 1,766 $29,121.34 1.12%
TransMedics Group, Inc. TMDX 89377M109 Medical Equipment and Services 380 $26,383.40 1.02%
Progyny, Inc. PGNY 74340E103 Health Care Providers 863 $22,317.18 0.86%
LifeStance Health Group, Inc. LFST 53228F101 Health Care Providers 2,783 $20,622.03 0.79%
PROCEPT BioRobotics Corporation PRCT 74276L105 Medical Equipment and Services 705 $19,620.15 0.76%
NeoGenomics, Inc. NEO 64049M209 Medical Equipment and Services 1,761 $19,194.90 0.74%
Alphatec Holdings, Inc. ATEC 02081G201 Medical Equipment and Services 2,351 $18,808.00 0.72%
Teladoc Health, Inc. TDOC 87918A105 Health Care Providers 2,580 $18,189.00 0.70%
Tandem Diabetes Care, Inc. TNDM 875372203 Medical Equipment and Services 915 $17,696.10 0.68%
Inspire Medical Systems, Inc. INSP 457730109 Medical Equipment and Services 403 $16,599.57 0.64%
Schrodinger, Inc. SDGR 80810D103 Software and Computer Services 773 $11,115.74 0.43%
QuidelOrtho Corporation QDEL 219798105 Medical Equipment and Services 620 $8,884.60 0.34%
US Dollar $USD Other 562 $562.35 0.02%
Holdings are subject to change.

The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.